Apoptosis Regulator Bcl-2 (BCL2) Antibody

Este producto es parte de BCL2 - BCL2 apoptosis regulator
Product Graph
299€ (100 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Apoptosis Regulator Bcl-2 (BCL2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx175547
tested applications
WB, IHC, IF/ICC

Description

B-Cell Leukemia/Lymphoma 2 (Bcl2) Antibody is a Rabbit Polyclonal antibody against B-Cell Leukemia/Lymphoma 2 (Bcl2).

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Apoptosis Regulator Bcl-2 (BCL2)
Host
Rabbit
Reactivity
Pig
Recommended Dilution
WB: 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Purification
Purified by antigen-specific affinity chromatography, followed by Protein A affinity chromatography.
Size 1
100 µl
Size 2
200 µl
Size 3
1 ml
Form
Liquid
Tested Applications
WB, IHC, IF/ICC
Buffer
0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol.
Availability
Shipped within 5-7 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Alias
Bcl-2,PPP1R50,B-Cell CLL/Lymphoma 2
Background
Antibody anti-BCL2
Status
RUO

Descripción

Related Products

FNab00839

BCL2 antibody

This gene encodes an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Alternative splicing results in multiple transcript variants.

Ver Producto
FNab00840

BCL2 antibody

Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor(APAF-1). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release(PubMed:17418785).

Ver Producto
P2028

Recombinant Human BCL2

Ver Producto